AN2 Therapeutics, Inc. ANTX Q1 2025 earnings
Reported May 13, 2025 · Before market open
EPS-$0.35Miss by $0.09
EPS estimate-$0.26
Next report
Aug 11, 2026 (In 1 week)EPS estimate-$0.23
Versus estimates
Diluted EPS
Ask the moment AN2 Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did AN2 Therapeutics, Inc. report Q1 2025 earnings?
- AN2 Therapeutics, Inc. (ANTX) reported Q1 2025 earnings on May 13, 2025 before market open.
- What were AN2 Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- AN2 Therapeutics, Inc. reported eps of $-0.35 for Q1 2025.
- Did AN2 Therapeutics, Inc. beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.26 by $0.09.
- How did AN2 Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 37.5% from $-0.56.
- Where can I find AN2 Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-070358) directly on SEC EDGAR. The filing index links above go to sec.gov.